These results suggest a more severe and pathological inflammation in the colon of Irf1−/− mutants than in B6 controls that more closely resembles transcriptional changes seen in human UC and that alterations in human IRF1 expression may be associated with IBD in humans. This evidence concerns the gene IRF1 and inflammatory bowel disease.